Association of Active Caspase 8 with the Mitochondrial Membrane During Apoptosis: Potential Roles in Cleaving BAP31 and Caspase 3 and Mediating Mitochondrion-endoplasmic Reticulum Cross Talk in Etoposide-induced Cell Death
Overview
Affiliations
It was recently demonstrated that during apoptosis, active caspase 9 and caspase 3 rapidly accumulate in the mitochondrion-enriched membrane fraction (D. Chandra and D. G. Tang, J. Biol. Chem.278:17408-17420, 2003). We now show that active caspase 8 also becomes associated with the membranes in apoptosis caused by multiple stimuli. In MDA-MB231 breast cancer cells treated with etoposide (VP16), active caspase 8 is detected only in the membrane fraction, which contains both mitochondria and endoplasmic reticulum (ER), as revealed by fractionation studies. Immunofluorescence microscopy, however, shows that procaspase 8 and active caspase 8 predominantly colocalize with the mitochondria. Biochemical analysis demonstrates that both procaspase 8 and active caspase 8 are localized mainly on the outer mitochondrial membrane (OMM) as integral proteins. Functional analyses with dominant-negative mutants, small interfering RNAs, peptide inhibitors, and Fas-associated death domain (FADD)- and caspase 8-deficient Jurkat T cells establish that the mitochondrion-localized active caspase 8 results mainly from the FADD-dependent and tumor necrosis factor receptor-associated death domain-dependent mechanisms and that caspase 8 activation plays a causal role in VP16-induced caspase 3 activation and cell death. Finally, we present evidence that the OMM-localized active caspase 8 can activate cytosolic caspase 3 and ER-localized BAP31. Cleavage of BAP31 leads to the generation of ER- localized, proapoptotic BAP20, which may mediate mitochondrion-ER cross talk through a Ca(2+)-dependent mechanism.
Asci H, Emre Akin S, Ekrem Camas H, Bindal A, Kurtbolat O, Tasan S Iran J Basic Med Sci. 2025; 28(3):323-331.
PMID: 39906615 PMC: 11790192. DOI: 10.22038/ijbms.2024.80608.17444.
Gharib E, Robichaud G Int J Mol Sci. 2024; 25(17).
PMID: 39273409 PMC: 11395697. DOI: 10.3390/ijms25179463.
Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer.
Naik A, Lattab B, Qasem H, Decock J Mol Ther Oncol. 2024; 32(1):200768.
PMID: 38596293 PMC: 10876628. DOI: 10.1016/j.omton.2024.200768.
Zheng Z, Su J, Bao X, Wang H, Bian C, Zhao Q Front Immunol. 2023; 14:1247268.
PMID: 37600785 PMC: 10436604. DOI: 10.3389/fimmu.2023.1247268.
Wei X, Li L, Zhao J, Huo Y, Hu X, Lu J Int J Biol Sci. 2023; 19(6):1713-1730.
PMID: 37063427 PMC: 10092757. DOI: 10.7150/ijbs.82178.